New

Serum Institute gets 'Covishield' purchase order from Centre

PTI Pune | Updated on January 11, 2021 Published on January 11, 2021

The Serum Institute on India on Monday said it has received the purchase order from the Centre for the Oxford-AstraZeneca Covid-19 vaccine.

"We have received the (purchase) order from the Government of India on Monday afternoon," a senior SII official told PTI.

The government has already announced that the process of administering the vaccine will start on on January 16.

The SII vaccine developed by Oxford-AstraZeneca was cleared for emergency use along with Bharat Biotech's indigenous "Covaxin" earlier this month.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on January 11, 2021
vaccines and immunisation
Covid-19
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.